Showing results (81-90 of 157) with videos related to
Sort By:
Pageof 16
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 5, 2016
Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate PioglitazoneMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2015
Clopidogrel Has No Clinically Meaningful Effect on the Pharmacokinetics of the Organic Anion Transporting Polypeptide 1B1 and Cytochrome P450 3A4 Substrate SimvastatinMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.British Journal of Clinical Pharmacology|January 31, 2018
Implications of intercorrelation between hepatic CYP3A4-CYP2C8 enzymes for the evaluation of drug-drug interactions: a case study with repaglinideKosuke Doki, Adam S Darwich, Brahim Achour, et al.British Journal of Clinical Pharmacology|October 9, 2015
Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60-year-old Caucasian woman with ovarian carcinomaTroels K Bergmann, Anne M Filppula, Terhi Launiainen, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 12, 2019
Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In HumansMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.Clinical Pharmacology and Therapeutics|October 4, 2005
Cyclosporine markedly raises the plasma concentrations of repaglinideLauri I Kajosaari, Mikko Niemi, Mikko Neuvonen, et al.Clinical and Translational Science|March 22, 2024
Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 functionKreetta Hämäläinen, Päivi Hirvensalo, Mikko Neuvonen, et al.Journal of Clinical Pharmacology|January 29, 2010
Long-term changes in cyclosporine pharmacokinetics after renal transplantation in children: evidence for saturable presystemic metabolism and effect of NR1I2 polymorphismSamuel Fanta, Siv Jönsson, Mats O Karlsson, et al.British Journal of Clinical Pharmacology|August 22, 2009
No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatinJenni E Keskitalo, Kaisa J Kurkinen, Mikko Neuvonen, et al.Clinical Pharmacology and Therapeutics|October 10, 2003
Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinideMikko Niemi, Julian B Leathart, Mikko Neuvonen, et al.Pageof 16